Reversibility of the interaction of CGP 11305 A with MAO A in vivo (Q48725551)

15 February 2018

title

Reversibility of the interaction of CGP 11305 A with MAO A in vivo (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90446-6

26 August 2023

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90446-6

26 August 2023

author name string

P. C. Waldmeier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6197309

26 August 2023

J. J. Feldtrauer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6197309

26 August 2023

K. Stoecklin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6197309

26 August 2023

E. Paul

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6197309

26 August 2023

language of work or name

English

0 references

publication date

1 October 1983

1 reference

15 February 2018

14 October 1983

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6197309

full work available at URL

26 August 2023

https://api.elsevier.com/content/article/PII:0014299983904466?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90446-6

https://api.elsevier.com/content/article/PII:0014299983904466?httpAccept=text/plain

26 August 2023

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90446-6

European Journal of Pharmacology

26 August 2023

published in

1 reference

15 February 2018

volume

94

1 reference

15 February 2018

issue

1-2

1 reference

15 February 2018

page(s)

101-108

1 reference

15 February 2018

The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90446-6

The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline

26 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90446-6

A new approach to the assessment of the potency of reversible monoamine oxidase inhibitors in vivo, and its application to (+)-amphetamine, p-methoxyamphetamine and harmaline

26 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90446-6

A method for the assay of conjugated 3,4-dihydroxyphenylglycol, a major noradrenaline metabolite in the rat brain

26 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90446-6

Preferential deamination of dopamine by an A type monoamine oxidase in rat brain

26 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90446-6

The monoamine oxidase inhibiting properties of CGP 11305 A.

26 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90446-6

Turnover of acid dopamine metabolites in striatal and mesolimbic tissue of the rat brain

26 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90446-6

A SENSITIVE AND SPECIFIC ASSAY FOR THE ESTIMATION OF MONOAMINE OXIDASE

26 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90446-6

26 August 2023

Identifiers

1 reference

15 February 2018

1 reference

15 February 2018